This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perez, P.
Right arrow Articles by Bravo, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perez, P.
Right arrow Articles by Bravo, R.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Jul 1995, 3523-3530, Vol 15, No. 7
Copyright © 1995, American Society for Microbiology

Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein I kappa B alpha

P Perez, SA Lira and R Bravo
Department of Molecular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000, USA.

RelA (p65) is one of the strongest activators of the Rel/NF-kappa B family. As a first step to elucidate the mechanisms that regulate its activity in vivo, we have generated transgenic mice overexpressing RelA in the thymus. Although the levels of RelA were significantly increased in thymocytes of transgenic mice, the overall NF-kappa B-binding activity in unstimulated cells was not augmented compared with that in control thymocytes. This could be explained by the dramatic increase of endogenous I kappa B alpha levels observed in RelA-overexpressing cells in both cytoplasmic and nuclear compartments. The ikba mRNA levels were not augmented by overexpressed RelA, but I kappa B alpha inhibitor was found to be stabilized through association with RelA. Although a fraction of RelA was associated with cytoplasmic p105, no changes in the precursor levels were observed. Upon stimulation of RelA- overexpressing thymocytes with phorbol 12-myristate 13-acetate and lectin (phytohemaglutinin), different kappa B-binding complexes, including RelA homodimers, were partially released from I kappa B alpha. Association of RelA with I kappa B alpha prevented complete degradation of the inhibitor. No effect of phorbol 12-myristate 13- acetate-lectin treatment was detected on RelA associated with p105. Our data indicate that cytoplasmic retention of overexpressed RelA by I kappa B alpha is the major in vivo mechanism controlling the potential excess of NF-kappa B activity in long-term RelA-overexpressing thymocytes.


This article has been cited by other articles:

  • Liberatore, R. A., Goff, S. P., Nunes, I. (2009). NF-{kappa}B activity is constitutively elevated in c-Abl null fibroblasts. Proc. Natl. Acad. Sci. USA 106: 17823-17828 [Abstract] [Full Text]  
  • Sumariwalla, P. F., Palmer, C. D., Pickford, L. B., Feldmann, M., Foxwell, B. M. J., Brennan, F. M. (2009). Suppression of tumour necrosis factor production from mononuclear cells by a novel synthetic compound, CLX-090717. Rheumatology (Oxford) 48: 32-38 [Abstract] [Full Text]  
  • Doan, L. L., Porter, S. D., Duan, Z., Flubacher, M. M., Montoya, D., Tsichlis, P. N., Horwitz, M., Gilks, C. B., Grimes, H. L. (2004). Targeted transcriptional repression of Gfi1 by GFI1 and GFI1B in lymphoid cells. Nucleic Acids Res 32: 2508-2519 [Abstract] [Full Text]  
  • Liu, J.-J., Hou, S.-C., Shen, C.-K. J. (2003). Erythroid Gene Suppression by NF-{kappa}B. J. Biol. Chem. 278: 19534-19540 [Abstract] [Full Text]  
  • Santos, M., Perez, P., Segrelles, C., Ruiz, S., Jorcano, J. L., Paramio, J. M. (2003). Impaired NF-kappa B Activation and Increased Production of Tumor Necrosis Factor alpha in Transgenic Mice Expressing Keratin K10 in the Basal Layer of the Epidermis. J. Biol. Chem. 278: 13422-13430 [Abstract] [Full Text]  
  • Doan, L. L., Kitay, M. K., Yu, Q., Singer, A., Herblot, S., Hoang, T., Bear, S. E., Morse, H. C. III, Tsichlis, P. N., Grimes, H. L. (2003). Growth Factor Independence-1B Expression Leads to Defects in T Cell Activation, IL-7 Receptor {alpha} Expression, and T Cell Lineage Commitment. J. Immunol. 170: 2356-2366 [Abstract] [Full Text]  
  • Malstrom, S., Tili, E., Kappes, D., Ceci, J. D., Tsichlis, P. N. (2001). Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. Proc. Natl. Acad. Sci. USA 98: 14967-14972 [Abstract] [Full Text]  
  • Ludwig, L., Kessler, H., Wagner, M., Hoang-Vu, C., Dralle, H., Adler, G., Bohm, B. O., Schmid, R. M. (2001). Nuclear Factor-{{kappa}}B Is Constitutively Active in C-Cell Carcinoma and Required for RET-induced Transformation. Cancer Res. 61: 4526-4535 [Abstract] [Full Text]  
  • Tabary, O., Escotte, S., Couetil, J. P., Hubert, D., Dusser, D., Puchelle, E., Jacquot, J. (1999). Genistein Inhibits Constitutive and Inducible NF{kappa}B Activation and Decreases IL-8 Production by Human Cystic Fibrosis Bronchial Gland Cells. Am. J. Pathol. 155: 473-481 [Abstract] [Full Text]  
  • Rudmann, D. G., Durham, S. K. (1999). Utilization of Genetically Altered Animals in the Pharmaceutical Industry. Toxicol Pathol 27: 111-114 [Abstract]  
  • Ishikawa, H., Claudio, E., Dambach, D., Raventos-Suarez, C., Ryan, C., Bravo, R. (1998). Chronic Inflammation and Susceptibility to Bacterial Infections in Mice Lacking the Polypeptide (p)105 Precursor (NF-{kappa}B1) but Expressing p50. JEM 187: 985-996 [Abstract] [Full Text]  
  • Attar, R. M., Macdonald-Bravo, H., Raventos-Suarez, C., Durham, S. K., Bravo, R. (1998). Expression of Constitutively Active Ikappa Bbeta in T Cells of Transgenic Mice: Persistent NF-kappa B Activity Is Required for T-Cell Immune Responses. Mol. Cell. Biol. 18: 477-487 [Abstract] [Full Text]  
  • Carrasco, D., Perez, P., Lewin, A., Bravo, R. (1997). I{kappa}B{alpha} Overexpression Delays Tumor Formation in v-rel Transgenic Mice. JEM 186: 279-288 [Abstract] [Full Text]  
  • Perona, R, Montaner, S, Saniger, L, Sanchez-Perez, I, Bravo, R, Lacal, J C (1997). Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins.. Genes Dev. 11: 463-475 [Abstract]  
  • Bachelerie, F, Rodriguez, M., Dargemont, C, Rousset, D, Thomas, D, Virelizier, J., Arenzana-Seisdedos, F (1997). Nuclear export signal of IkappaBalpha interferes with the Rev-dependent posttranscriptional regulation of human immunodeficiency virus type I. J. Cell Sci. 110: 2883-2893 [Abstract]  
  • Arenzana-Seisdedos, F, Turpin, P, Rodriguez, M, Thomas, D, Hay, R., Virelizier, J., Dargemont, C (1997). Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J. Cell Sci. 110: 369-378 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»